August 13, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreJuly 24, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJuly 30, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreAugust 06, 2026
According to market projections, the global spectrometry market, valued at USD 23.79 billion in 2026, is anticipated to reach USD 47.43 billion by 2035, growing at a CAGR of 7.97% over the next decade. The growing research and development, increasing investments & collaborations, and the rising prevalence of chronic disorders drive the market....
August 06, 2026
According to Payal Rabde, who specializes in cardiac arrhythmia diagnosis, electrophysiology studies, cardiac ablation procedures, and EP mapping and navigation systems, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the electrophysiology market. The global electroph...
August 05, 2026
According to market projections, the autoimmune hepatitis diagnosis and treatment sector is expected to grow from USD 14.49 billion in 2026 to USD 20.71 billion by 2035, reflecting a CAGR of 3.3%. The autoimmune hepatitis diagnosis and treatment market focuses on tests and therapies for managing autoimmune hepatitis, a condition where the immune sy...
August 05, 2026
According to market projections, the newborn screening sector is expected to grow from USD 3.9 billion in 2026 to USD 6.87 billion by 2035, reflecting a CAGR of 6.5%. The market is growing due to rising demand for preventive care, advanced diagnostic technologies, and increased awareness of testing. Recent highlights include the GUARDIAN study usin...
August 05, 2026
According to Payal Rabde, who specializes in molecular diagnostics, immunodiagnostics, hematology diagnostics, and in-vitro diagnostic testing, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the clinical diagnostics market. The global clinical diagnostics market size...
August 04, 2026
Based on market forecasts, the stroke diagnostics and therapeutics sector will expand from USD 43.71 billion in 2026 to USD 81.71 billion by 2035, experiencing a CAGR of 7.2%. Stroke diagnostics and therapeutics focus on quickly identifying and treating strokes to prevent brain damage and improve recovery. Advanced imaging, biomarkers, and AI help ...
August 03, 2026
Market insights predict the global hemato-oncology testing industry will increase from USD 4 billion in 2025 to USD 12.88 billion by 2035, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the top focus, making up 40% of the market. PCR technology dominated testing methods with a 45% share, val...
August 03, 2026
According to Payal Rabde, who specializes in early detection and screening, cancer diagnosis and treatment monitoring, and detection of circulating tumor DNA (ctDNA), circulating tumor cells, and exosomes, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the U.S. liqui...
July 31, 2026
Market insights predict the global pancreatic cancer industry will increase from USD 3.42 billion in 2026 to USD 10.87 billion by 2035, achieving a CAGR of 13.7%. Pancreatic cancer is a deadly disease that starts in the pancreas, an organ that helps digest food and regulate blood sugar. It often grows silently, showing few symptoms until it spreads...
July 28, 2026
According to Payal Rabde, who specializes in early cancer detection and diagnosis, companion diagnostics for targeted therapies, and genomic, proteomic, and transcriptomic biomarker analysis with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the oncology biomarker market...
+1 804 441 9344
+65 3106 5601 or +91 87933 22019
